Lixte Biotech Hlds
(LIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,358 | -756 | -383 | -2,440 | N/A |
| Accounts payable and accrued liabilities | -28 | 15 | 17 | N/A | N/A |
| Other Working Capital | -99 | 58 | -31 | 18 | N/A |
| Other Operating Activity | 1,093 | -86 | -17 | 749 | 0 |
| Operating Cash Flow | $-1,392 | $-769 | $-414 | $-1,674 | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -130 | -56 | 0 | 0 | 0 |
| Financing Cash Flow | $-130 | $-56 | $N/A | $0 | $N/A |
| Beginning Cash Position | 2,599 | 2,599 | 2,599 | 4,273 | N/A |
| End Cash Position | 1,076 | 1,774 | 2,185 | 2,599 | N/A |
| Net Cash Flow | $-1,523 | $-825 | $-414 | $-1,674 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,392 | -769 | -414 | -1,674 | N/A |
| Free Cash Flow | -1,392 | -769 | -414 | -1,674 | 0 |